Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F I Carroll

Showing results (191-200 of 208) with videos related to

Pageof 21
Sort By:
Nuclear Medicine and Biology|April 1, 1996
Synthesis and in vivo studies of a selective ligand for the dopamine transporter: 3 beta-(4-[125I]iodophenyl) tropan-2 beta-carboxylic acid isopropyl ester ([125I]RTI-121)J R Lever, U Scheffel, M Stathis, et al.
Molecular Pharmaceutics|April 25, 2019
Formulation and Characterization of Conjugate Vaccines to Reduce Opioid Use Disorders Suitable for Pharmaceutical Manufacturing and Clinical EvaluationF Baruffaldi, M D Raleigh, S J King, et al.
Psychopharmacology|April 25, 2012
Effects of the specific α4β2 nAChR antagonist, 2-fluoro-3-(4-nitrophenyl) deschloroepibatidine, on nicotine reward-related behaviors in rats and miceK M Tobey, D M Walentiny, J L Wiley, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1995
Studies of the biogenic amine transporters. V. Demonstration of two binding sites for the cocaine analog [125I]RTI-55 associated with the 5-HT transporter in rat brain membranesM L Silverthorn, C M Dersch, M H Baumann, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1995
Studies of the biogenic amine transporters. VI. Characterization of a novel cocaine binding site, identified with [125I]RTI-55, in membranes prepared from whole rat brain minus caudateR B Rothman, M L Silverthorn, M H Baumann, et al.
Synapse (New York, N.Y.)|March 28, 1998
Studies of the biogenic amine transporters. VII. Characterization of a novel cocaine binding site identified with [125I]RTI-55 in membranes prepared from human, monkey and guinea pig caudateR B Rothman, M L Silverthorn, J R Glowa, et al.
Nuclear Medicine and Biology|April 1, 1996
Evaluation of [11C]RTI-121 as a selective radioligand for PET studies of the dopamine transporterS P Hume, S K Luthra, D J Brown, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1994
Studies of the biogenic amine transporters. IV. Demonstration of a multiplicity of binding sites in rat caudate membranes for the cocaine analog [125I]RTI-55R B Rothman, J L Cadet, H C Akunne, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1994
Studies of the biogenic amine transporters. III. Demonstration of two binding sites for [3H]GBR12935 and [3H]BTCP in rat caudate membranesH C Akunne, C M Dersch, J L Cadet, et al.
Synapse (New York, N.Y.)|April 3, 1999
Opioid peptide receptor studies, 11: involvement of Tyr148, Trp318 and His319 of the rat mu-opioid receptor in binding of mu-selective ligandsH Xu, Y F Lu, J S Partilla, et al.
Pageof 21

Showing results (191-200 of 208) with videos related to

Sort By:
Pageof 21
Nuclear Medicine and Biology|April 1, 1996
Synthesis and in vivo studies of a selective ligand for the dopamine transporter: 3 beta-(4-[125I]iodophenyl) tropan-2 beta-carboxylic acid isopropyl ester ([125I]RTI-121)J R Lever, U Scheffel, M Stathis, et al.
Molecular Pharmaceutics|April 25, 2019
Formulation and Characterization of Conjugate Vaccines to Reduce Opioid Use Disorders Suitable for Pharmaceutical Manufacturing and Clinical EvaluationF Baruffaldi, M D Raleigh, S J King, et al.
Psychopharmacology|April 25, 2012
Effects of the specific α4β2 nAChR antagonist, 2-fluoro-3-(4-nitrophenyl) deschloroepibatidine, on nicotine reward-related behaviors in rats and miceK M Tobey, D M Walentiny, J L Wiley, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1995
Studies of the biogenic amine transporters. V. Demonstration of two binding sites for the cocaine analog [125I]RTI-55 associated with the 5-HT transporter in rat brain membranesM L Silverthorn, C M Dersch, M H Baumann, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1995
Studies of the biogenic amine transporters. VI. Characterization of a novel cocaine binding site, identified with [125I]RTI-55, in membranes prepared from whole rat brain minus caudateR B Rothman, M L Silverthorn, M H Baumann, et al.
Synapse (New York, N.Y.)|March 28, 1998
Studies of the biogenic amine transporters. VII. Characterization of a novel cocaine binding site identified with [125I]RTI-55 in membranes prepared from human, monkey and guinea pig caudateR B Rothman, M L Silverthorn, J R Glowa, et al.
Nuclear Medicine and Biology|April 1, 1996
Evaluation of [11C]RTI-121 as a selective radioligand for PET studies of the dopamine transporterS P Hume, S K Luthra, D J Brown, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1994
Studies of the biogenic amine transporters. IV. Demonstration of a multiplicity of binding sites in rat caudate membranes for the cocaine analog [125I]RTI-55R B Rothman, J L Cadet, H C Akunne, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1994
Studies of the biogenic amine transporters. III. Demonstration of two binding sites for [3H]GBR12935 and [3H]BTCP in rat caudate membranesH C Akunne, C M Dersch, J L Cadet, et al.
Synapse (New York, N.Y.)|April 3, 1999
Opioid peptide receptor studies, 11: involvement of Tyr148, Trp318 and His319 of the rat mu-opioid receptor in binding of mu-selective ligandsH Xu, Y F Lu, J S Partilla, et al.
Pageof 21